KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors: Description of Clinical Research Protocol of the KINDEST-CCS Study

BACKGROUND: Approximately 30% of childhood cancer survivors (CCSs) will develop chronic kidney disease (CKD) or hypertension 15 to 20 years after treatment ends. The incidence of CKD and hypertension in the 5-year window after cancer therapy is unknown. Moreover, extent of monitoring of CCS with CKD...

Descripción completa

Detalles Bibliográficos
Autores principales: Khondker, Adree, Groff, Michael, Nunes, Sophia, Sun, Carolyn, Jawa, Natasha, Lee, Jasmine, Cockovski, Vedran, Hejri-Rad, Yasmine, Chanchlani, Rahul, Fleming, Adam, Garg, Amit, Jeyakumar, Nivethika, Kitchlu, Abhijat, Lebel, Asaf, McArthur, Eric, Mertens, Luc, Nathan, Paul, Parekh, Rulan, Patel, Serina, Pole, Jason, Ramphal, Raveena, Schechter, Tal, Silva, Mariana, Silver, Samuel, Sung, Lillian, Wald, Ron, Gibson, Paul, Pearl, Rachel, Wheaton, Laura, Wong, Peter, Kim, Kirby, Zappitelli, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Clinical Research Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618744/
https://www.ncbi.nlm.nih.gov/pubmed/36325265
http://dx.doi.org/10.1177/20543581221130156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618744/
https://www.ncbi.nlm.nih.gov/pubmed/36325265
http://dx.doi.org/10.1177/20543581221130156

Ejemplares similares